[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA200796"], "brand_name": ["EDARBI"], "generic_name": ["AZILSARTAN KAMEDOXOMIL"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "product_ndc": ["60631-040", "60631-080"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AZILSARTAN KAMEDOXOMIL"], "rxcui": ["1091646", "1091650", "1091652", "1091654"], "spl_id": ["2f63b0e8-977a-4d22-9550-29ad1926a9de"], "spl_set_id": ["52b27c75-9f5a-4816-bafd-dace9d7d2063"], "package_ndc": ["60631-040-07", "60631-040-30", "60631-040-77", "60631-080-07", "60631-080-30", "60631-080-77"], "is_original_packager": [true], "upc": ["0360631080308", "0360631040302"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0429-2021", "product_description": "Edarbi (azilsartan medoxomil) tablets 80 mg 30 Tablets Rx Only NDC 60631-080-30 Manufactured for: arbor Pharmaceuticals Atlanta, GA 30328", "product_quantity": "328 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "78902-1"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205649"], "brand_name": ["XIGDUO"], "generic_name": ["DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-6225", "0310-6270", "0310-6280", "0310-6250", "0310-6260"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DAPAGLIFLOZIN PROPANEDIOL", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1593058", "1593068", "1593070", "1593072", "1593775", "1593831", "1593833", "1593835", "1940496", "1940498"], "spl_id": ["a8717b28-9445-4292-9ac7-e979f378d9c8"], "spl_set_id": ["ac8a0f7b-9f69-4495-abbc-3a47cd75a859"], "package_ndc": ["0310-6270-30", "0310-6270-95", "0310-6280-30", "0310-6280-95", "0310-6250-30", "0310-6250-95", "0310-6260-30", "0310-6260-60", "0310-6260-94", "0310-6260-95", "0310-6225-60", "0310-6225-94"], "is_original_packager": [true], "unii": ["887K2391VH", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0435-2021", "product_description": "xigduo XR (dapgliflozin/metformin HCl extended-release) tablets 10 mg/1000 mg 30 Tablets Rx only NDC 0310-6280-30 Manufactured for: AstraZeneca Pharmaceuticals LP Wilmington, DE 19850  Manufactured by: Bristol-Myers Squibb Manufacturing Company Humacao, Puerto Rico 00791", "product_quantity": "664 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "MP0077"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA761061"], "brand_name": ["TREMFYA"], "generic_name": ["GUSELKUMAB"], "manufacturer_name": ["Janssen Biotech, Inc."], "product_ndc": ["57894-640", "57894-650", "57894-651"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["GUSELKUMAB"], "spl_id": ["88e658ff-da0d-4022-85ed-1cd5e02f64af"], "spl_set_id": ["1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56"], "package_ndc": ["57894-650-01", "57894-650-02", "57894-640-01", "57894-640-04", "57894-640-11", "57894-640-99", "57894-640-03", "57894-640-06", "57894-651-01", "57894-651-02", "57894-651-04", "57894-651-11", "57894-651-22", "57894-651-99", "57894-651-92"], "is_original_packager": [true], "nui": ["N0000192799", "N0000192798"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "unii": ["089658A12D"]}, "product_type": "Drugs", "event_id": "87489", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "AL, LA, MS, TN", "recall_number": "D-0314-2021", "product_description": "Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA  19044; NDC 57894-640-01.", "product_quantity": "48 boxes", "reason_for_recall": "Temperature Abuse", "recall_initiation_date": "20210309", "center_classification_date": "20210329", "termination_date": "20211104", "report_date": "20210407", "code_info": "KESOY.AI Exp. 04/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA207932"], "brand_name": ["BELBUCA"], "generic_name": ["BUPRENORPHINE HYDROCHLORIDE"], "manufacturer_name": ["BioDelivery Sciences International Inc"], "product_ndc": ["59385-021", "59385-022", "59385-023", "59385-024", "59385-025", "59385-026", "59385-027"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["BUCCAL"], "substance_name": ["BUPRENORPHINE HYDROCHLORIDE"], "rxcui": ["1716057", "1716063", "1716065", "1716067", "1716069", "1716071", "1716073", "1716075", "1716077", "1716079", "1716081", "1716083", "1716086", "1716090"], "spl_id": ["d8541d8a-992a-4b62-8518-ecd85f480e67"], "spl_set_id": ["bc2b7a3d-72cf-497c-95b0-ba2b71f63c64"], "package_ndc": ["59385-021-01", "59385-021-60", "59385-022-01", "59385-022-60", "59385-023-01", "59385-023-60", "59385-024-01", "59385-024-60", "59385-025-01", "59385-025-60", "59385-026-01", "59385-026-60", "59385-027-01", "59385-027-60"], "is_original_packager": [true], "unii": ["56W8MW3EN1"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0448-2021", "product_description": "Belbuca (buprenorphine hydrochloride) buccal film 300 mcg 60 pouches containing 1 buccal film each Rx only NDC 59385-023-60 Manufactured for: BioDelivery Sciences International, Inc. Raleigh, NC 27612.", "product_quantity": "96 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "37674B"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0503-2021", "product_description": "Infants Aqueous Vitamin D Oral Drops 400 IU/mL 50 mL (1 2/3 fl oz) Manufactrued by: Silarx Pharmaceuticals, Inc. 19 West Street Spring Valley, NY 10977 USA", "product_quantity": "422 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0401-2021", "product_description": "NIACIN 250MG 110; NDC/UPC 740985228494; OTC; TABLETS", "product_quantity": "4 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA212728"], "brand_name": ["NURTEC ODT"], "generic_name": ["RIMEGEPANT SULFATE"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["72618-3000", "72618-3001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIMEGEPANT SULFATE"], "rxcui": ["2282313", "2282320"], "spl_id": ["de776fbe-e6ca-4930-9fe9-1fb6162d50ab"], "spl_set_id": ["9ef08e09-1098-35cc-e053-2a95a90a3e1d"], "package_ndc": ["72618-3000-2", "72618-3001-1", "72618-3001-2"], "is_original_packager": [true], "unii": ["1383NM3Q0H"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0451-2021", "product_description": "NURTEC ODT (RIMEGEPANT) 75MG 8 BPK; NDC/UPC 72618-3000-2; RX; TABLETS FOR RAPID DISSOLUTION (NOT SUBLINGUAL)", "product_quantity": "1240 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "4170326"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208699"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-321", "68462-322", "68462-323", "68462-324"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["9c80244b-f111-425c-bf4c-c8cc91300cce"], "spl_set_id": ["32d0e130-1211-44ca-be60-5379ffec96fd"], "package_ndc": ["68462-321-90", "68462-321-10", "68462-321-30", "68462-322-30", "68462-322-90", "68462-322-10", "68462-323-30", "68462-323-90", "68462-323-05", "68462-324-30", "68462-324-90", "68462-324-05"], "is_original_packager": [true], "upc": ["0368462321300", "0368462322307", "0368462323304"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0484-2021", "product_description": "EZETIMIBE AND SIMVASTATIN TABLETS 10-10MG 30; NDC/UPC 68462-321-30; RX; TABLETS", "product_quantity": "7 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "17201603"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0467-2021", "product_description": "Iron 100 with Vitamin C Tablets Dietary Supplement 100 Tablets NDC 60258-099-01 Distributed By: Cypress Pharmaceutical, Inc. 135 Industrial Blvd. Madison, MS 39110", "product_quantity": "1 bottle", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Ogden", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87809", "recalling_firm": "Fresenius Medical Care, North America", "address_1": "475 W 13th St", "address_2": "N/A", "postal_code": "84404-5554", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0389-2021", "product_description": "Delflex Peritoneal Dialysis Solution with 1.5% Dextrose, LM/LC, packaged in a case containing 2 x 6 Liter bags, Rx only, NDC 49230-206-60, Fresenius Medical Care North America, Waltham, MA 02451", "product_quantity": "709 cases", "reason_for_recall": "Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.", "recall_initiation_date": "20210414", "center_classification_date": "20210519", "termination_date": "20220405", "report_date": "20210526", "code_info": "Lot #20SU03019, Exp 6/2022"}, {"status": "Terminated", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["DRY EYE TEST"], "generic_name": ["FLUORESCEIN SODIUM"], "manufacturer_name": ["Nomax Inc."], "product_ndc": ["51801-008"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["FLUORESCEIN SODIUM"], "spl_id": ["7490418c-b489-4b90-bc3d-33ed71231e2d"], "spl_set_id": ["04866053-f973-471e-b3bc-241fb76303a2"], "package_ndc": ["51801-008-15"], "is_original_packager": [true], "unii": ["93X55PE38X"]}, "product_type": "Drugs", "event_id": "87695", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0387-2021", "product_description": "Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15", "product_quantity": "78 cartons", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210413", "center_classification_date": "20210518", "termination_date": "20230928", "report_date": "20210526", "code_info": "LOT 13336 EXP 07/23"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077336"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-142", "62756-143"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "spl_id": ["69a60382-bf12-4627-baaf-2e0ac332b443"], "spl_set_id": ["41a8bb80-7b0b-476c-8134-5d161c3239c8"], "package_ndc": ["62756-142-01", "62756-142-02", "62756-143-01"], "is_original_packager": [true], "upc": ["0362756142015", "0362756143012"], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "87617", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0325-2021", "product_description": "Metformin HCl Extended-Release Tablets, USP, 500 mg, Rx Only, 500-count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Industries Ltd., Halol-Baroda HIghway, Halol-389 350 Gujarat, India, NDC 62756-142-02.", "product_quantity": "2520 bottles", "reason_for_recall": "Failed Moisture Limits: Out of specification for water content", "recall_initiation_date": "20210325", "center_classification_date": "20210407", "termination_date": "20220414", "report_date": "20210414", "code_info": "Lot #JKU4639A, Exp 10/2022"}, {"status": "Terminated", "city": "Libertyville", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["A-S Medication Solutions"], "product_ndc": ["50090-5350"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["198440"], "spl_id": ["987708d0-122e-47da-8591-0a0ea7979aad"], "spl_set_id": ["c4f0f591-8501-4c6d-bf8e-ca3068ff65b5"], "package_ndc": ["50090-5350-0", "50090-5350-1"], "original_packager_product_ndc": ["0904-6730"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "87436", "recalling_firm": "A-S Medication Solutions LLC.", "address_1": "2401 Commerce Dr", "address_2": "N/A", "postal_code": "60048-4464", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0358-2021", "product_description": "Acetaminophen, Extra Strength, Aspirin Free, 500 MG Tablets, 100-count bottles, Mfr: Major Pharmaceuticals, Livonia, MI 48152; Packaged Exclusively By: A-S Medication Solutions LLC, Libertyville, IL 60048, Product # 6967-0;  NDC: 50090-5350-0; contained within Health Essentials Kit, Kit Contains: 1 bottle hand sanitzer, 1 reusable face mask, 1 bottle Acetaminophen 500 mg, 1 bag cough drops, 1 digital thermometer, 50 disposable gloves.", "product_quantity": "201,600 kits", "reason_for_recall": "Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label.", "recall_initiation_date": "20210302", "center_classification_date": "20210430", "termination_date": "20250423", "report_date": "20210512", "code_info": "Lots 323206, 323207, 323208, 335353, 335354, 335355, 335356, 335358, 335359,335360, 335361, 335362, 335395, 352116, Expiry 7/31/2022; 323209, 323210, 323211, 323212, 323213, 323214, 323215, 323216, 323218, 323219, 323220, 323222, 323223, 323224, 323238, 335363, 335364, 335365, 335366, 335367, 335368, 335369, 335370, 335371, 335372, 335373, 335374, 335375, 335376, 335377, Expiry 8/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0471-2021", "product_description": "Ivermectin Tablets USP 3 mg 20 Tablets (2 Foil Strips of 10 tablets each) Rx Only NDC 4799-806-01 Manufactured for: Edenbridge Pharmaceuticals, LLC Parsippany, NJ 07054 877-381-3336", "product_quantity": "504 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "A1003273A"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0375-2021", "product_description": "Haloperidol Decanoate Injection, USP 50 mg/mL, 1 mL Single Dose Vials, Rx Only, Sterile, 10 Vials, Teva Pharmaceuticals, USA, Inc., North Wales, PA NDC 00703-7121-03", "product_quantity": "3150 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "Lot # 31325793C, exp. date 09/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209720"], "brand_name": ["ERYTHROMYCIN"], "generic_name": ["ERYTHROMYCIN"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1484", "69238-1485"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ERYTHROMYCIN"], "rxcui": ["197650", "598006"], "spl_id": ["61ae864e-1e74-40c1-b67f-22ea1e6f9f21"], "spl_set_id": ["0aaf09b7-a78b-4525-a857-ef12e3f4b2f9"], "package_ndc": ["69238-1484-3", "69238-1484-1", "69238-1485-3", "69238-1485-1"], "is_original_packager": [true], "upc": ["0369238148411", "0369238148534", "0369238148435", "0369238148510"], "nui": ["N0000009982", "N0000175877", "N0000175935", "M0028311"], "pharm_class_pe": ["Decreased Sebaceous Gland Activity [PE]"], "pharm_class_epc": ["Macrolide [EPC]", "Macrolide Antimicrobial [EPC]"], "pharm_class_cs": ["Macrolides [CS]"], "unii": ["63937KV33D"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0424-2021", "product_description": "ERYTHROMYCIN TABLETS, USP 250MG 30; NDC/UPC 69238-1484-3; RX; TABLETS", "product_quantity": "135 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AM200540"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0345-2021", "product_description": "ChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution -Clear, 0.10 fl. oz. (3ml) each, 25 applicators per carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-01 Cat. No. 260400", "product_quantity": "11,115,774 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0008777, 12/31/2022;  0016325, 12/31/2022;  0021072, 1/31/2023;  0027041, 1/31/2023;  0030959, 1/31/2023;  0031090, 1/31/2023;  0044735, 1/31/2023;  0048062, 2/28/2023;  0052110, 2/28/2023;  0056365, 2/28/2023;  0086148, 2/28/2023;  0104864, 3/31/2023;  0192894, 6/30/2023;  8081571, 3/31/2021;  8086851, 3/31/2021;  8087784, 3/31/2021;  8095620, 3/31/2021;  8106737, 4/30/2021;  8107819, 4/30/2021;  8124917, 4/30/2021;  8130509, 4/30/2021;  8131816, 4/30/2021;  8135646, 5/31/2021;  8141808, 5/31/2021;  8149992, 5/31/2021;  8155991, 5/31/2021;  8162912, 5/31/2021;  8163900, 5/31/2021;  8165721, 6/30/2021;  8176743, 6/30/2021;  8187644, 6/30/2021;  8194993, 6/30/2021;  8199884, 7/31/2021;  8201565, 7/31/2021;  8205560, 7/31/2021;  8206895, 7/31/2021;  8207995, 7/31/2021;  8221939, 7/31/2021;  8228634, 8/31/2021;  8235981, 8/31/2021;  8247508, 8/31/2021;  8264554, 9/30/2021;  8289654, 9/30/2021;  8299615, 10/31/2021;  8304783, 10/31/2021;  8311788, 10/31/2021;  8316776, 10/31/2021;  8332585, 11/30/2021;  8333924, 11/30/2021;  8337646, 11/30/2021;  8337647, 11/30/2021;  8338794, 11/30/2021;  8340914, 11/30/2021;  8352585, 12/31/2021;  8354835, 12/31/2021;  9007921, 12/31/2021;  9015917, 12/31/2021;  9015920, 12/31/2021;  9030934, 1/31/2022;  9043625, 1/31/2022;  9045819, 1/31/2022;  9046572, 2/28/2022;  9052554, 2/28/2022;  9059817, 2/28/2022;  9060734, 2/28/2022;  9071761, 2/28/2022;  9080812, 3/31/2022;  9087980, 3/31/2022;  9087982, 3/31/2022;  9088850, 3/31/2022;  9092575, 3/31/2022;  9100768, 3/31/2022;  9101529, 3/31/2022;  9105675, 3/31/2022;  9113528, 4/30/2022;  9123753, 4/30/2022;  9130718, 4/30/2022;  9133928, 4/30/2022;  9135816, 5/31/2022;  9149671, 5/31/2022;  9150905, 5/31/2022;  9154935, 5/31/2022;  9156866, 5/31/2022;  9165856, 5/31/2022;  9189224, 6/30/2022;  9194257, 6/30/2022;  9196196, 6/30/2022;  9198900, 6/30/2022;  9199815, 6/30/2022;  9200420, 6/30/2022;  9205441, 7/31/2022;  9206555, 7/31/2022;  9233323, 8/31/2022;  9233645, 8/31/2022;  9236531, 8/31/2022;  9238871, 8/31/2022;  9241929, 8/31/2022;  9242192, 8/31/2022;  9246940, 8/31/2022;  9246944, 8/31/2022;  9249460, 8/31/2022;  9251683, 8/31/2022;  9253785, 8/31/2022;  9254193, 8/31/2022;  9255899, 8/31/2022;  9257889, 8/31/2022;  9261886, 9/30/2022;  9266348, 9/30/2022;  9270894, 9/30/2022;  9278673, 9/30/2022;  9280666, 9/30/2022;  9284872, 9/30/2022;  9289666, 9/30/2022;  9291336, 10/31/2022;  9293445, 10/31/2022;  9295140, 10/31/2022;  9297772, 10/31/2022;  9304891, 10/31/2022;  9305777, 10/31/2022;  9311057, 10/31/2022;  9316346, 11/30/2022;  9325127, 11/30/2022;  9326162, 11/30/2022;  9331792, 11/30/2022;  9344775, 11/30/2022;  9345956, 11/30/2022;  9345958, 11/30/2022;  9350617, 12/31/2022;  9352330, 12/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0322-2021", "product_description": "Sp-4, 100 mL solution bottles, Rx only, Washington Homeopathic Products, Inc.260 J R Hawvermale Way  Berkeley Springs West Virginia 25411", "product_quantity": "114 bottles", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 24844, 25500, 26310"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086195"], "brand_name": ["PROCTOFOAM"], "generic_name": ["PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE"], "manufacturer_name": ["Viatris Specialty LLC"], "product_ndc": ["0037-6822"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROCORTISONE ACETATE", "PRAMOXINE HYDROCHLORIDE"], "rxcui": ["828362", "828364"], "spl_id": ["d63033a1-dca0-44f9-a6f3-210e38c2691e"], "spl_set_id": ["3831e931-ec0a-11e3-ac10-0800200c9a66"], "package_ndc": ["0037-6822-10"], "is_original_packager": [true], "unii": ["3X7931PO74", "88AYB867L5"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0529-2021", "product_description": "Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol 10 g net wt Rx Only NDC 0037-6822-10 Distributed by: Meda Pharmaceutical Inc. Somerset, New Jersey", "product_quantity": "834 aerosol containers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "33119"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0414-2021", "product_description": "Vaniqa (eflornithine hydrochloride) Cream, 13.9% For Topical Use Only Net wt. 1.59 oz (45 g) Rx only NDC 0023-4857-45 Manufactured for Allegan, Inc. Irvine, CA 92612", "product_quantity": "72 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "113780"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206321"], "brand_name": ["SAXENDA"], "generic_name": ["LIRAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2800"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["LIRAGLUTIDE"], "rxcui": ["897122", "1598268"], "spl_id": ["49c3d82d-a708-46b2-a273-6ea032afa5c3"], "spl_set_id": ["3946d389-0926-4f77-a708-0acb8153b143"], "package_ndc": ["0169-2800-15", "0169-2800-90", "0169-2800-97"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["839I73S42A"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0618-2021", "product_description": "Saxenda (liraglutide) Injection, 18 mg/3 mL (6 mg/mL), 1 x 3 mL Prefilled Pen, Sample. Not for Resale., Rx only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-2800-90 (Pen), NDC 0169-2800-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "K1620A1 (Kit); KZFH714 (Pen) exp 05/31/2022;   B2020A (Kit); JZFF482 (Pen) exp 11/30/2021;   I2320A (Kit); KZFH714 (Pen) exp 05/31/2022;   H1020A (Kit); KZFH714 (Pen) exp 05/31/2022;  J0520A(Kit); KZFH714 (Pen) exp 05/31/2022"}, {"status": "Terminated", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87531", "recalling_firm": "PNHC, LLC.", "address_1": "1105 Baslow Brook Ct", "address_2": "N/A", "postal_code": "27614-8863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "FL, CA", "recall_number": "D-0365-2021", "product_description": "heal the world, moisturizing original hand sanitizer, Non-Sterile Solution, Alcohol Antiseptic, 70% Topical Solution, 9.6 FL OZ. (285 mL) bottle, Heal The World, LLC, Draper, UT 84020, UPC 6 19988 44038 0.", "product_quantity": "139,806 bottles", "reason_for_recall": "Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.", "recall_initiation_date": "20210310", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210512", "code_info": "Lots: SAA21, SAA24, SAA27, SAA22, SAA23, SAA29, SAA26, SAA28, SAA25, SAA32, SAA55, SAA56, SAA44, SAA60, expiration 5/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0511-2021", "product_description": "MICONAZOLE 7 2% 45GM APL; NDC/UPC 009047734459; OTC; CREAM", "product_quantity": "71 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87455", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0318-2021", "product_description": "ZOMA-Jet 10 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 10 mg vial, ZOMA-Jet 10 Demonstration Kit contains -ZOMA-Jet 10 device - 7 Needle-Free Head A's - 1 Carrying Case - 1 User Manual; Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054; UPC 3 55566 19031 4.", "product_quantity": "1569 devices", "reason_for_recall": "Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.", "recall_initiation_date": "20210311", "center_classification_date": "20210330", "termination_date": "20230607", "report_date": "20210407", "code_info": "201827020015  201826020065  201835320058  201835320009  201834920003  201835220007  201901820009  201901420200  201902120010  201901120019  201901420005  201901020180  201901520015  201900720001  201900920004  201904620003  201902120011  201904420007  201904520015  201904920002  201905020111  201904620004  201905720011  201907320003  201907320030  201907820007  201907420017  201910820009  201915620014  201910920016  201910620017  201910820020  201911320048  201911320095  201913720148  201912920021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA087385"], "brand_name": ["TRIAMCINOLONE ACETONIDE"], "generic_name": ["TRIAMCINOLONE ACETONIDE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-049", "45802-054", "45802-055"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["TRIAMCINOLONE ACETONIDE"], "rxcui": ["1085633", "1085636", "1085640"], "spl_id": ["13c13dae-7f5d-4b1f-af06-c62dfdcf8f1c"], "spl_set_id": ["838ba2fa-5133-4975-bd99-791891a144c5"], "package_ndc": ["45802-054-35", "45802-054-05", "45802-054-36", "45802-055-35", "45802-055-36", "45802-055-05", "45802-049-35"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["F446C597KA"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0551-2021", "product_description": "Triamcinolone Acetonide Ointment, USP, 0.025% 80g; Rx Only, Distributed by: Perrigo, Allegan, MI 49010,NDC 45802-054-36", "product_quantity": "178 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "0MT0286"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0558-2021", "product_description": "PROMETHAZINE PLAIN ORAL SOLUTION 6.25MG/5ML 473ML; ; RX; SOLUTION (USUALLY NOT OTIC, OPTH, NASAL DROPS), Rx Only, NDC 0211-0927-16", "product_quantity": "49 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "20001481"}, {"status": "Ongoing", "city": "Elmwood Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87751", "recalling_firm": "QMart", "address_1": "495 Mola Blvd", "address_2": "N/A", "postal_code": "07407-2041", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0368-2021", "product_description": "IMPERIAL GOLD 2000, Male Sexual Performance Enhancement, 1 Capsule, UPC 718122040702", "product_quantity": "200 boxes", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.", "recall_initiation_date": "20210331", "center_classification_date": "20210506", "report_date": "20210512", "code_info": "All"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA020986"], "brand_name": ["NOVOLOG"], "generic_name": ["INSULIN ASPART"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2100", "0169-7501", "0169-3303", "0169-6339", "0169-6338", "0169-2001", "0169-2101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "351926", "1653196", "1653198", "1653202", "1653204"], "spl_id": ["de82c22d-ea25-44ef-8bcd-c3cda9e84e59"], "spl_set_id": ["3a1e73a2-3009-40d0-876c-b4cb2be56fc5"], "package_ndc": ["0169-7501-11", "0169-7501-90", "0169-3303-12", "0169-3303-91", "0169-3303-90", "0169-6339-10", "0169-6339-90", "0169-6339-97", "0169-6339-98", "0169-6338-10", "0169-6338-90", "0169-6338-97", "0169-2001-90", "0169-2100-11", "0169-2101-12", "0169-2101-25"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX", "059QF0KO0R"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0615-2021", "product_description": "NovoLog FlexPen (insulin aspart) Injection, 100 units/mL, 3 mL Prefilled Insulin Syringe pen, Sample. Not for Resale, Rx Only, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6339-90 (Pen), NDC 0169-6339-98 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BS11, Exp 11/30/2021"}, {"status": "Ongoing", "city": "Ridgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87711", "recalling_firm": "Hyobin LLC", "address_1": "455 S Pleasant Ave", "address_2": "N/A", "postal_code": "07450-5413", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0382-2021", "product_description": "PremierZen Black 5000, packaged in   cardboard blisters containing one capsule per card, Distributed by Yolo Studio,  Cliffside Park, NJ", "product_quantity": "500 cards", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.", "recall_initiation_date": "20210406", "center_classification_date": "20210514", "report_date": "20210526", "code_info": "all lots"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205551"], "brand_name": ["TRIUMEQ"], "generic_name": ["ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE"], "manufacturer_name": ["ViiV Healthcare Company"], "product_ndc": ["49702-231", "49702-258"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ABACAVIR SULFATE", "DOLUTEGRAVIR SODIUM", "LAMIVUDINE"], "rxcui": ["1546888", "1546894", "2598348", "2598352"], "spl_id": ["0202cd67-c6e6-452c-85a7-8ccbdcfdf1e1"], "spl_set_id": ["2997739a-aa91-42aa-a206-a70e2db7b84f"], "package_ndc": ["49702-231-13", "49702-258-37", "49702-272-59"], "is_original_packager": [true], "upc": ["0349702231139"], "nui": ["N0000175656", "N0000175462", "N0000009947"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "unii": ["J220T4J9Q2", "1Q1V9V5WYQ", "2T8Q726O95"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0486-2021", "product_description": "Triumeq (abacavir, dolutegravir, and lamivudine) 600 mg/50 mg/300 mg Tablets 30 Tablets Rx Only NDC 49702-231-13 Manufactured for: Viiv Healthcare Research Triangle Park, NC 27709 by GlaxoSmithKline Research Triangle Park, NC 27709", "product_quantity": "2264 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "GS5G"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0563-2021", "product_description": "medroxyprogesterone acetate injectable suspension, USP,  150MG/ML 1ML, Rx Only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-4538-02", "product_quantity": "148 syringes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "DN0428"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0452-2021", "product_description": "CATAPRES-TTS-2 1X4; NDC/UPC 597003234; RX; ADHESIVE PATCHES", "product_quantity": "17 patches", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1905666/2"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0440-2021", "product_description": "ONDANSETRON HCL 4MG 30; NDC/UPC 65862018730; RX; TABLETS", "product_quantity": "1935 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "ON0420015-A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0415-2021", "product_description": "UBRELVY 100MG 10UD CPLT; NDC/UPC 23650110; RX; TABLETS", "product_quantity": "964 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1658641"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0560-2021", "product_description": "Intrarosa Prasterone Vaginal Inserts 6.5 mg 28 inserts/applicators Rx Only Manufactured for: Ednoceutics, Inc. Quebec City, Canada, G1V 4M7 Distributed by: AMAG Pharmaceuticals, Inc. Waltam, MA 02451, NDC 64011-601-28", "product_quantity": "205 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "R81339"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0562-2021", "product_description": "Medroxyprogesterone acetate injectable suspension, USP 150 mg per mL 1 mL Prefilled Syringe Rx only NDC 59762-4538-2 Distributed by: Greenstone, LLC. Peapack, NJ 07977", "product_quantity": "286 syringes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EC4744"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210708"], "brand_name": ["ELETRIPTAN HYDROBROMIDE"], "generic_name": ["ELETRIPTAN HYDROBROMIDE"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-104", "59651-105"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELETRIPTAN HYDROBROMIDE"], "rxcui": ["359493", "359494"], "spl_id": ["f505017a-a5d7-4f9a-a62f-06a28b30f645"], "spl_set_id": ["bb5ea5df-4add-420d-88cb-6dabe116ca65"], "package_ndc": ["59651-104-06", "59651-104-69", "59651-105-06", "59651-105-69", "59651-105-93"], "is_original_packager": [true], "upc": ["0359651105696"], "unii": ["M41W832TA3"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0438-2021", "product_description": "Eletriptan Hydrobromide Tablets 20 mg* 6(1x6) Unit-dose Tablets Rx only NDC 59651-104-69 Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Highstown Road East Windsor, NJ 08520", "product_quantity": "20 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EA2020001-A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209664"], "brand_name": ["PREGABALIN"], "generic_name": ["PREGABALIN"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "product_ndc": ["43598-291", "43598-292", "43598-293", "43598-294", "43598-295", "43598-296", "43598-297", "43598-298"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREGABALIN"], "rxcui": ["483438", "483440", "483442", "483444", "483446", "483448", "483450", "577127"], "spl_id": ["4a1e5038-d049-606f-c087-48bc353a8a69"], "spl_set_id": ["ceed457b-8f43-4021-fd70-071c96e09470"], "package_ndc": ["43598-291-90", "43598-291-05", "43598-291-79", "43598-291-66", "43598-291-78", "43598-292-90", "43598-292-05", "43598-292-79", "43598-292-66", "43598-292-78", "43598-293-90", "43598-293-05", "43598-293-79", "43598-293-66", "43598-293-78", "43598-294-90", "43598-294-05", "43598-294-79", "43598-294-66", "43598-294-78", "43598-295-90", "43598-295-05", "43598-295-79", "43598-295-66", "43598-295-78", "43598-296-90", "43598-296-05", "43598-296-79", "43598-296-66", "43598-296-78", "43598-297-90", "43598-297-05", "43598-297-79", "43598-297-66", "43598-297-78", "43598-298-90", "43598-298-05", "43598-298-79", "43598-298-66", "43598-298-78"], "is_original_packager": [true], "unii": ["55JG375S6M"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0469-2021", "product_description": "PREGABALIN CAPSULES 300MG 90 ; NDC 43598-298-90; RX; CAPSULES", "product_quantity": "6 CONTAINERS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "T2000309"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 120"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-328"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["208545", "1923809"], "spl_id": ["b12c988d-27b2-4548-83c0-a6837ada2db3"], "spl_set_id": ["00046231-8fab-44a0-b986-9a9dd450881d"], "package_ndc": ["42192-328-30", "42192-328-01", "42192-328-07"], "is_original_packager": [true], "upc": ["0342192328013"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0399-2021", "product_description": "NP Thyroid 120 Thyroid Tablets, USP 2 grain (120 mg), packaged in a) 100-count bottles (NDC 42192-328-01) and b) 7-count bottles (NDC 42192-328-07) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 69,289 bottles; b) 9,076 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lot #: a) M328H19-2B, M328J19-11, M328J19-2A, M328J19-3A, M328J19-4A M328J19-5A, M328J19-6A, M328J19-7A, Exp. 08/31/2021, M328K19-2,  M328K19-4A, Exp. 09/30/2021; b) M328J19-9B Exp. 08/31/2021"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA203752"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-3410", "68968-3425", "68968-3437", "68968-3450", "68968-3475"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["241946", "242891", "242892", "248478", "1149632"], "spl_id": ["4d2e5c5f-d82f-4a2c-bfa5-2899fb283696"], "spl_set_id": ["bf185599-2138-4083-9c52-2b95dce09ae0"], "package_ndc": ["68968-3425-8", "68968-3437-8", "68968-3450-8", "68968-3475-8", "68968-3410-8"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "87741", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0337-2021", "product_description": "Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186  Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8", "product_quantity": "10872 cartons", "reason_for_recall": "Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.", "recall_initiation_date": "20210416", "center_classification_date": "20210420", "termination_date": "20241011", "report_date": "20210428", "code_info": "Lot #: 88321 Exp. 02/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Ridgewood", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87711", "recalling_firm": "Hyobin LLC", "address_1": "455 S Pleasant Ave", "address_2": "N/A", "postal_code": "07450-5413", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0383-2021", "product_description": "Triple SupremeZen Plus 3500, packaged in   cardboard blisters containing one capsule per card, Distributed by Yolo Studio,  Cliffside Park, NJ", "product_quantity": "300 cards", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.", "recall_initiation_date": "20210406", "center_classification_date": "20210514", "report_date": "20210526", "code_info": "all lots"}, {"status": "Terminated", "city": "Cliffside Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87630", "recalling_firm": "Bit & Bet LLC", "address_1": "25 Oakdene Ave", "address_2": "N/A", "postal_code": "07010-3009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0388-2021", "product_description": "Thumbs Up 7 Blue 69K, 10 capsules, Distributed by Ummzy LLC., Made in USA, UPC 617135894673.    Packaged in blister foil sheets in a box. Each box contains 10 capsules.", "product_quantity": "3894 ten-count boxes (38,940 capsules)", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.", "recall_initiation_date": "20210324", "center_classification_date": "20210518", "termination_date": "20210716", "report_date": "20210526", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87545", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ", "recall_number": "D-0320-2021", "product_description": "Ganirelix Acetate Injection, 250 mcg/0.5 mL, Sterile Prefilled Syringe, Rx only, Distributor: Ferring Pharmaceuticals, Inc., Parsippany, NJ 07054 USA, Manufactured by: Sun Pharmaceutical Industries Ltd, Halol, Gujarat, India Made in India, NDC 55566-1000-1.", "product_quantity": "91,211 syringes", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210315", "center_classification_date": "20210402", "termination_date": "20230606", "report_date": "20210414", "code_info": "Lots JKU1212A, JKU1503A, JKU1504A, JKU1505A, JKU1506A, Exp 03/2021; JKU3313A & JKU3314A, Exp 08/2021."}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 30"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-329"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313387", "1724439"], "spl_id": ["0d4e00fa-0373-4c35-9a05-777328f6c41c"], "spl_set_id": ["2eabc9b4-2d5c-44b2-bf05-eb6c3260c1bd"], "package_ndc": ["42192-329-30", "42192-329-01", "42192-329-10", "42192-329-07"], "is_original_packager": [true], "upc": ["0342192329102"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0396-2021", "product_description": "NP Thyroid 30 Thyroid Tablets, USP 1/2 grain (30 mg), packaged in a) 100-count bottles (NDC 42192-329-01) and b) 7-count bottles (NDC 42192-329-07), Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005", "product_quantity": "a) 113,019 bottles; b) 44,900 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: a) M329D20-1, M329D20-2, M329D20-3 Exp. 03/31/2022, ; b) M329D20-2 Exp. 03/31/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0493-2021", "product_description": "LEUCOVORIN 15MG 24; NDC/UPC 54449810; RX; TABLETS", "product_quantity": "12 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "064159A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205209"], "brand_name": ["DARIFENACIN"], "generic_name": ["DARIFENACIN"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "product_ndc": ["13668-202", "13668-203"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DARIFENACIN HYDROBROMIDE"], "rxcui": ["485421", "485423"], "spl_id": ["bd53ab8c-821a-4a1b-bcda-4fed3bbd6382"], "spl_set_id": ["e84f1ae3-b9a2-4a15-a299-c75373891cc1"], "package_ndc": ["13668-202-30", "13668-202-90", "13668-202-05", "13668-203-30", "13668-203-05", "13668-203-90"], "is_original_packager": [true], "upc": ["0313668203301", "0313668202304"], "unii": ["CR02EYQ8GV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0584-2021", "product_description": "Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only,  Manufactured by: Torrent Pharmaceuticals, LTD Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-203-30", "product_quantity": "37 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BDZ9G005"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0456-2021", "product_description": "Synjardy (empagliflozin and metformin hydrochloride) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0168-69 Distributed by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "284 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "C80102"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87547", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to MD, CO & TX only", "recall_number": "D-0323-2021", "product_description": "LCL-2-0191, 5 gallon carboys, Rx only, Manufactured for: LaCore Labs, LLC, by: Washington Homeopathic Products, Inc.260 J R Hawvermale Way Berkeley Springs West Virginia 25411", "product_quantity": "300 liters", "reason_for_recall": "An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.", "recall_initiation_date": "20210318", "center_classification_date": "20210405", "termination_date": "20210513", "report_date": "20210414", "code_info": "Lot # 28506"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205649"], "brand_name": ["XIGDUO"], "generic_name": ["DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-6225", "0310-6270", "0310-6280", "0310-6250", "0310-6260"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DAPAGLIFLOZIN PROPANEDIOL", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1593058", "1593068", "1593070", "1593072", "1593775", "1593831", "1593833", "1593835", "1940496", "1940498"], "spl_id": ["a8717b28-9445-4292-9ac7-e979f378d9c8"], "spl_set_id": ["ac8a0f7b-9f69-4495-abbc-3a47cd75a859"], "package_ndc": ["0310-6270-30", "0310-6270-95", "0310-6280-30", "0310-6280-95", "0310-6250-30", "0310-6250-95", "0310-6260-30", "0310-6260-60", "0310-6260-94", "0310-6260-95", "0310-6225-60", "0310-6225-94"], "is_original_packager": [true], "unii": ["887K2391VH", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0436-2021", "product_description": "xigduo XR (dapagliflozin/metformin HCl extended-release) tablets 5 mg/1000 mg 60 Tablets Rx only NDC 0310-6260-60 Manufactured for: AstraZeneca Pharmaceuticals LP Wilmington, DE 19850", "product_quantity": "378 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "ML0171"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87631", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0331-2021", "product_description": "Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.", "product_quantity": "62,040 tubes", "reason_for_recall": "Failed Stability Specifications: product did not meet viscosity results.", "recall_initiation_date": "20210329", "center_classification_date": "20210412", "termination_date": "20240703", "report_date": "20210421", "code_info": "Lot 13269, Exp March 2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206763"], "brand_name": ["OLMESARTAN MEDOXOMIL"], "generic_name": ["OLMESARTAN MEDOXOMIL"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-445", "67877-446", "67877-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OLMESARTAN MEDOXOMIL"], "rxcui": ["349373", "349401", "349405"], "spl_id": ["a1d66aa9-d0fa-4d21-bba0-ff8078c2e5af"], "spl_set_id": ["142b735a-e1cd-46e1-a523-3ef061001bf9"], "package_ndc": ["67877-445-30", "67877-445-90", "67877-445-05", "67877-445-10", "67877-446-30", "67877-446-90", "67877-446-05", "67877-446-10", "67877-446-33", "67877-446-84", "67877-446-74", "67877-446-38", "67877-447-30", "67877-447-90", "67877-447-05", "67877-447-10"], "is_original_packager": [true], "upc": ["0367877445304"], "unii": ["6M97XTV3HD"]}, "product_type": "Drugs", "event_id": "87817", "recalling_firm": "Ascend Laboratories LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0392-2021", "product_description": "Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.", "product_quantity": "34296 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20230217", "report_date": "20210602", "code_info": "Batch No. 20122548, Exp Date: Aug. 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0447-2021", "product_description": "DEXAMETH SOD PHOS 0.1% 5ML; NDC/UPC 24208072002; RX; DROPS", "product_quantity": "318 droptainers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "353351"}, {"status": "Terminated", "city": "Rockford", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA091623"], "brand_name": ["THIAMINE HYDROCHLORIDE"], "generic_name": ["THIAMINE HYDROCHLORIDE"], "manufacturer_name": ["Mylan Institutional LLC"], "product_ndc": ["67457-196"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["THIAMINE HYDROCHLORIDE"], "rxcui": ["313324"], "spl_id": ["cbc5513d-4341-455c-b435-53dd5624efaa"], "spl_set_id": ["12986d0e-b8bf-4338-9d85-07f973b35439"], "package_ndc": ["67457-196-00", "67457-196-02"], "is_original_packager": [true], "unii": ["M572600E5P"]}, "product_type": "Drugs", "event_id": "87803", "recalling_firm": "Mylan Institutional LLC", "address_1": "4901 Hiawatha Dr", "address_2": "", "postal_code": "61103-1287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0601-2021", "product_description": "Thiamine HCl Injection, USP 200 mg/2 mL (100mg/mL), 2 mL vials, packaged in 25 (2 mL multi-dose vial) per carton, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA; Manufactured by: Mylan Institutional, Galway, Ireland. NDC: 67457-196-02", "product_quantity": "2,131 cartons", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.", "recall_initiation_date": "20210503", "center_classification_date": "20210601", "termination_date": "20221018", "report_date": "20210609", "code_info": "Lot #: 200906, Exp. Date February 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209482"], "brand_name": ["TRELEGY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0887", "0173-0893"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE", "UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1945039", "1945044", "1945047", "1945048", "2395769", "2395771", "2395774", "2395775"], "spl_id": ["676a0120-5f94-4470-b936-2c8cfb32d3fc"], "spl_set_id": ["b5a81d5a-4648-4c7a-951d-33c014a63c7e"], "package_ndc": ["0173-0887-10", "0173-0887-14", "0173-0887-61", "0173-0893-10", "0173-0893-14", "0173-0893-61"], "is_original_packager": [true], "unii": ["40AHO2C6DG", "7AN603V4JV", "JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0481-2021", "product_description": "TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMEDIDINIUM AND VILANTEROL INHALATION POWDER) 100-62.5-25MCG 60; NDC/UPC 0173-0893-10; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "4065 CARTON", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "FN2J"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0492-2021", "product_description": "LITHIUM CARB 150MG 100; NDC/UPC 54252625; RX; CAPSULES", "product_quantity": "298 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "AB1024A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210705"], "brand_name": ["FENOFIBRATE"], "generic_name": ["FENOFIBRATE"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "product_ndc": ["27241-118", "27241-119", "27241-120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FENOFIBRATE"], "rxcui": ["200311", "310288", "310289"], "spl_id": ["2dffe879-0f18-4961-b1a9-0d69565a04a6"], "spl_set_id": ["da2f0ba4-7c16-4fb0-bc1c-45540e8fefbf"], "package_ndc": ["27241-118-04", "27241-118-05", "27241-119-04", "27241-119-05", "27241-120-04", "27241-120-05"], "is_original_packager": [true], "upc": ["0327241119040", "0327241118043", "0327241120046"], "nui": ["N0000175596", "N0000175375", "M0199111"], "pharm_class_epc": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]"], "pharm_class_moa": ["Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"], "pharm_class_cs": ["PPAR alpha [CS]"], "unii": ["U202363UOS"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0407-2021", "product_description": "FENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULES", "product_quantity": "106 BOXES", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "PA03410"}, {"status": "Terminated", "city": "Bensalem", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA206107"], "brand_name": ["ASENAPINE"], "generic_name": ["ASENAPINE"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "product_ndc": ["42794-016", "42794-017"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBLINGUAL"], "substance_name": ["ASENAPINE"], "rxcui": ["859975", "859981"], "spl_id": ["f1f1f3b2-6b49-a523-e053-2995a90ad0c9"], "spl_set_id": ["3512687b-d1c7-45c4-8822-3a2ad53575a5"], "package_ndc": ["42794-016-22", "42794-016-08", "42794-016-10", "42794-017-22", "42794-017-08", "42794-017-10"], "is_original_packager": [true], "upc": ["0342794016226", "0342794017100", "0342794016080", "0342794016103", "0342794017087", "0342794017223"], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["JKZ19V908O"]}, "product_type": "Drugs", "event_id": "87748", "recalling_firm": "SigmaPharm Laboratories LLC", "address_1": "3375 Progress Dr", "address_2": "N/A", "postal_code": "19020-5801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0379-2021", "product_description": "Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020    NDC 42794-016-10.", "product_quantity": "6266 bottles", "reason_for_recall": "Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent", "recall_initiation_date": "20210419", "center_classification_date": "20210514", "termination_date": "20220926", "report_date": "20210526", "code_info": "Lots # 2012501, 2012601 , 2012701, & 2100701, Exp. AUG 2022"}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210221"], "brand_name": ["CEPHALEXIN"], "generic_name": ["CEPHALEXIN"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."], "product_ndc": ["68788-7529"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEPHALEXIN"], "rxcui": ["309113"], "spl_id": ["f170357f-5fe8-4ad4-983a-5e46245070cb"], "spl_set_id": ["6c7bfa58-2d38-4607-8c33-485ba4931c68"], "package_ndc": ["68788-7529-1", "68788-7529-2"], "original_packager_product_ndc": ["67877-545"], "unii": ["OBN7UDS42Y"]}, "product_type": "Drugs", "event_id": "87719", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "recalled product was distributed to three physicians located CA", "recall_number": "D-0342-2021", "product_description": "Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only, Repackaged by Preferred Pharmaceuticals, Inc., Mfg: Ascend Laboratories, LLC, NDC #: 68788-7529-1,", "product_quantity": "Six bottles", "reason_for_recall": "Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin", "recall_initiation_date": "20210412", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "Lot #: B1121W, Exp.Date: 04/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87455", "recalling_firm": "Ferring Pharmaceuticals Inc", "address_1": "100 Interpace Pkwy", "address_2": "", "postal_code": "07054-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0317-2021", "product_description": "ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 5mg vial, Rx only, ZOMA-Jet 5 Demonstration Kit contains -ZOMA-Jet 5 device - 5 Needle-Free Head A's - 2 Vial Adaptors - 1 Carrying Case - 1 User Manual; Manufactured for: Ferring Pharmaceuticals Inc. Parsippany, NJ 07054; UPC 3 55566 18031 5.", "product_quantity": "301 devices", "reason_for_recall": "Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.", "recall_initiation_date": "20210311", "center_classification_date": "20210330", "termination_date": "20230607", "report_date": "20210407", "code_info": "201601320031  201702320207  201731220039  201817120044  201912720086  201912320044", "more_code_info": ""}, {"status": "Terminated", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87608", "recalling_firm": "Cosette Pharmaceuticals, Inc.", "address_1": "111 Coolidge St", "address_2": "N/A", "postal_code": "07080-3801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0327-2021", "product_description": "Mometasone Furoate Topical Solution, USP, 0.1%, (Lotion), a) 30 mL (NDC 0713-0701-85) and b) 60 mL (NDC 0713-0701-53), Rx Only, Distributed by: Cosette Pharmaceuticals, Inc., South Plainfield, NJ 07080", "product_quantity": "a) 30 mL: 7724 b) 60 mL: 8064 bottles", "reason_for_recall": "CGMP Deviaitons", "recall_initiation_date": "20210325", "center_classification_date": "20210407", "termination_date": "20230717", "report_date": "20210414", "code_info": "a) 30 mL: 1014611 and 1014612, exp 12/2022    b) 60 mL:1014593, 1014594 and 1014595, exp 10/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0406-2021", "product_description": "METHOCARBAMOL 500MG 500; NDC/UPC 71093014005; RX; TABLETS", "product_quantity": "51 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "UMETA0036A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0515-2021", "product_description": "VITAMIN D3 25MCG 90 TABLETS; NDC/UPC 880681168004; OTC; TABLETS", "product_quantity": "53 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Ridgefield Park", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87613", "recalling_firm": "S & B Story LLC", "address_1": "30 Railroad Ave", "address_2": "N/A", "postal_code": "07660-1347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0352-2021", "product_description": "Imperial Extreme 2000 Capsules, 2000 mg, 1 count blister cards, distributed S&B Shopper LLC. Little Ferry, NJ UPC 7 18122 04073 5", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.", "recall_initiation_date": "20210325", "center_classification_date": "20210426", "report_date": "20210505", "code_info": "all lots and expirys", "more_code_info": ""}, {"country": "United States", "city": "Simpsonville", "address_1": "1071 Holland Rd Ste 2", "reason_for_recall": "Labeling: Incorrect Exp. Date: Incorrect BUD.", "address_2": "", "product_quantity": "109 syringes", "code_info": "Lots: K10521042 and K20521043 Exp. 08/31/2021.", "center_classification_date": "20210702", "distribution_pattern": "Distributed in South Carolina", "state": "SC", "product_description": "Ketamine HCl Injection Solution, 10 mg / 2 mL (5 mg/mL), Rx Only, Compounded by Prisma Health Outsourcing Facility 1071 Holland Rd. Suite 2 Simpsonville, SC 29681.  NDC: 73463-0100-01", "report_date": "20210623", "classification": "Class III", "openfda": {}, "recalling_firm": "Prisma Health Outsourcing Facility", "recall_number": "D-0648-2021", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "88097", "termination_date": "20210921", "more_code_info": "", "recall_initiation_date": "20210608", "postal_code": "29681-5709", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065129"], "brand_name": ["CEFIXIME"], "generic_name": ["CEFIXIME"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-405", "68180-407", "68180-416", "68180-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFIXIME"], "rxcui": ["309058", "409823", "419849"], "spl_id": ["735f86f4-369c-4f5a-adbe-7dacea2e27b4"], "spl_set_id": ["6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"], "package_ndc": ["68180-405-01", "68180-407-03", "68180-407-04", "68180-416-08", "68180-416-11", "68180-423-11", "68180-423-08"], "is_original_packager": [true], "upc": ["0368180423089", "0368180407034", "0368180416081", "0368180416111"], "unii": ["97I1C92E55"]}, "product_type": "Drugs", "event_id": "87871", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0390-2021", "product_description": "Cefixime for Oral Suspension USP 100 mg/5mL, 50mL HDPE bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc. Baltimore, Maryland, 21202 United States, Manufactured by: Lupin Limited, Manddeep, 462 046, India, NDC 68180-405-01", "product_quantity": "3,138 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210519", "termination_date": "20220222", "report_date": "20210526", "code_info": "Lot #: F900787, Exp. Date 4/2021"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0374-2021", "product_description": "Leucovorin Calcium for Injection, equivalent to leucovorin 350 mg/vial (20 mg/mL), Rx Only, FOR IM or IV Use, Sterile, Teva Parenteral Medicines, Inc., Irvine, CA  NDC 0703-5145-01; ALSO LABELED UNDER: NOVAPLUS, Manufactured By: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-5145-91 (Novaplus, a registered trademark of Vizient, Inc.)", "product_quantity": "192,277 cartons/1 single dose vial per carton", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "NDC 0703-5145-01: Lot # 31325332B, exp. date 08/2021, Lot # 31325756B, exp. date 09/2021 AND NDC 0703-5145-91: Lot # 31325685B, exp. date 09/2021"}, {"status": "Terminated", "city": "Horseheads", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87500", "recalling_firm": "X-Gen Pharmaceuticals Inc.", "address_1": "300 Daniel Zenker Dr", "address_2": "N/A", "postal_code": "14845-1014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0328-2021", "product_description": "Neomycin Sulfate Tablets, USP 500mg, Rx Only, 10x10 Unit dose 100 Tablets,  Manufactured for: X-GEN Phamaceuticals, Inc. Big Flats, NY 14814. NDC 39822-0310-5", "product_quantity": "720  100-count (10x10 blister strips)", "reason_for_recall": "Failed Stability Specifications:  Out of Specification (OOS) result reported for microbiological assay", "recall_initiation_date": "20210319", "center_classification_date": "20210408", "termination_date": "20221207", "report_date": "20210414", "code_info": "Lot # CFMBX, EXP 9/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202870"], "brand_name": ["METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE"], "generic_name": ["METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "product_ndc": ["62332-115", "62332-116", "62332-117"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "METOPROLOL TARTRATE"], "rxcui": ["866479", "866482", "866491"], "spl_id": ["10e75c6b-f79e-4424-b4c1-0ea73a98c64d"], "spl_set_id": ["2b77f66f-6891-4977-be8f-7955473d2f92"], "package_ndc": ["62332-115-30", "62332-115-31", "62332-115-91", "62332-116-30", "62332-116-31", "62332-116-71", "62332-117-30", "62332-117-31", "62332-117-71", "2005005745"], "is_original_packager": [true], "upc": ["0362332115303"], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "W5S57Y3A5L"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0412-2021", "product_description": "Metoprolol Tartrate and Hydrochlorothiazide Tablets, USP 50 mg/25 mg 100 Tablets Rx only NDC 62332-115-31 Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807 USA", "product_quantity": "71 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2005005745"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011719"], "brand_name": ["METHOTREXATE"], "generic_name": ["METHOTREXATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-350", "61703-408"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["METHOTREXATE SODIUM"], "rxcui": ["1655956", "1946772"], "spl_id": ["95b8b8da-da4e-4bba-9038-3cf65f3d5c1a"], "spl_set_id": ["0d63ba29-b692-41b4-87e8-351265c8273f"], "package_ndc": ["61703-350-37", "61703-350-38", "61703-408-41"], "is_original_packager": [true], "unii": ["3IG1E710ZN"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0553-2021", "product_description": "Methotrexate Injection, USP 50 mg/2mL (25 mg/mL) 5 x 2mL Single-Dose Vials, Sterile, Rx Only, Distributed by Hospira, Inc. Lake Forest, IL 60045. NDC 61703-350-38.", "product_quantity": "341 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "H074437AA"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022433"], "brand_name": ["BRILINTA"], "generic_name": ["TICAGRELOR"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-0776", "0186-0777"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TICAGRELOR"], "rxcui": ["1116635", "1116639", "1666332", "1666334"], "spl_id": ["716d1c45-09f7-4a1a-86a9-8f3c3243980e"], "spl_set_id": ["f7b3f443-e83d-4bf2-0e96-023448fed9a8"], "package_ndc": ["0186-0777-08", "0186-0777-60", "0186-0777-18", "0186-0777-39", "0186-0777-28", "0186-0776-60", "0186-0776-94"], "is_original_packager": [true], "nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["GLH0314RVC"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0433-2021", "product_description": "Brilinta ticagrelar tablets 60 mg 60 tablets Rx only NDC 0186-0776-60 Mfd. for: AstraZeneca LP, Wilmington, DE 19850", "product_quantity": "1278 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "MP0138"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0443-2021", "product_description": "LOTEMAX SM (loteprednol etabonate ophthalmic gel) 0.38% 5GM; NDC/UPC 24208-0507-07; RX; GEL", "product_quantity": "463 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "352162"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA074891"], "brand_name": ["ACYCLOVIR"], "generic_name": ["ACYCLOVIR"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-227", "23155-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ACYCLOVIR"], "rxcui": ["197311", "197313"], "spl_id": ["6e0a075f-822f-457d-8ccc-e63a16746d76"], "spl_set_id": ["0de2f5c7-9e75-4bdf-9c28-e026cc6694b4"], "package_ndc": ["23155-227-01", "23155-227-05", "23155-228-01", "23155-228-05"], "is_original_packager": [true], "upc": ["0323155227017", "0323155228014"], "nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "unii": ["X4HES1O11F"]}, "product_type": "Drugs", "event_id": "87762", "recalling_firm": "Heritage Pharmaceuticals Inc", "address_1": "1 Tower Center Blvd Ste 1700", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH", "recall_number": "D-0367-2021", "product_description": "Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01.    Packaged in 150 cc white HDPE bottle", "product_quantity": "408 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20210421", "center_classification_date": "20210506", "termination_date": "20220609", "report_date": "20210512", "code_info": "Lot A120036, Exp DEC 2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA060304"], "brand_name": ["NEOMYCIN SULFATE"], "generic_name": ["NEOMYCIN SULFATE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1177"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NEOMYCIN SULFATE"], "rxcui": ["866042"], "spl_id": ["18e9e5b7-e08c-445e-86bb-90bc0953eda9"], "spl_set_id": ["777dbfab-f83e-4738-ae1e-78619a9f82a7"], "package_ndc": ["0093-1177-01"], "is_original_packager": [true], "upc": ["0300931177018"], "unii": ["057Y626693"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0574-2021", "product_description": "NEOMYCIN SULF TABLETS, USP, 500mg, 100-count bottle, Rx Only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC: 0093-1177-01", "product_quantity": "41 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3006910"}, {"status": "Terminated", "city": "Maumee", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87633", "recalling_firm": "Spartan Chemical Co Inc", "address_1": "1110 Spartan Dr", "address_2": "N/A", "postal_code": "43537-1725", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico; Mexico", "recall_number": "D-0360-2021", "product_description": "foamyiQ Lemon Blossom Hand Sanitizer (benzalkonium chloride 0.1%), Net Contents: 42.27 oz/1250 ml per foam pump cartridge, For Institutional and Industrial Use Only, Spartan Chemical Company, Inc., 1110 Spartan Drive, Maumee, OH 43537 USA. UPC 7 53727 26454 4 NDC: 64009-202-06", "product_quantity": "26,328 cartridges", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210329", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210421", "code_info": "Lot, expiry: Lot 526756, exp 9/22/2022; Lot 527499, exp 9/28/2022; Lot 527501, exp 9/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021395"], "brand_name": ["SPIRIVA"], "generic_name": ["TIOTROPIUM BROMIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RESPIRATORY (INHALATION)"], "substance_name": ["TIOTROPIUM BROMIDE MONOHYDRATE"], "rxcui": ["485032", "580261"], "spl_id": ["902426f3-c843-416d-a1e3-b64eafc1f32d"], "spl_set_id": ["820839ef-e53d-47e8-a3b9-d911ff92e6a9"], "package_ndc": ["0597-0075-41", "0597-0075-75", "0597-0075-47"], "is_original_packager": [true], "unii": ["L64SXO195N"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0453-2021", "product_description": "Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per capsule Rx only NDC 0597-0075-41 Manufactured by: Boehringer Ingelheim (BI) Pharma GmbH & Co. KG Ingelheim, Germany  Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Pfizer, Inc. New York, NY 10017 USA", "product_quantity": "2611 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "5098"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0497-2021", "product_description": "Tylenol Acetaminophen Pain Regular Strength Liquid Gels Pain Reliever Fever Reducer 20 Liquid Gels 325 mg each NDC 50580-487-20", "product_quantity": "37 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Ongoing", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87548", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.", "recall_number": "D-0330-2021", "product_description": "Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608", "product_quantity": "N/A", "reason_for_recall": "Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.", "recall_initiation_date": "20210319", "center_classification_date": "20210412", "report_date": "20210421", "code_info": "Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0460-2021", "product_description": "PRAVACHOL 40MG 90; NDC/UPC 3519410; RX; TABLETS", "product_quantity": "3 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "ABA4203A1"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA210450"], "brand_name": ["ORILISSA"], "generic_name": ["ELAGOLIX"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-0038", "0074-0039"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELAGOLIX SODIUM"], "rxcui": ["2049852", "2049858", "2049860", "2049862"], "spl_id": ["fe82adb5-4113-48ee-844a-dd3ccc4a3dbd"], "spl_set_id": ["a86757b3-09c5-fd3b-1223-244e94f50a66"], "package_ndc": ["0074-0038-28", "0074-0038-01", "0074-0038-07", "0074-0039-56", "0074-0039-01", "0074-0039-14"], "is_original_packager": [true], "unii": ["5948VUI423"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0403-2021", "product_description": "Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodium, 28 Tablets For 28 Days Rx only NDC 0074-0038-28  Each carton contains 28 tablets in 4 weekly blister pack, Each weekly blister pack contains 7 tablets of elagolix 150 mg AbbVie Inc. North Chicago, IL 60064", "product_quantity": "210 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1120778"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA202331"], "brand_name": ["EDARBYCLOR"], "generic_name": ["AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)"], "product_ndc": ["60631-412", "60631-425"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AZILSARTAN KAMEDOXOMIL", "CHLORTHALIDONE"], "rxcui": ["1235144", "1235150", "1235151", "1235157"], "spl_id": ["26b92714-c5ea-943d-e063-6394a90a8341"], "spl_set_id": ["e60f795b-fce3-4361-aa03-f143451689d1"], "package_ndc": ["60631-412-30", "60631-425-30"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0430-2021", "product_description": "edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40 mg*/12.5 mg 30 Tablets Rx Only NDC 60631-412-30 Manufactured for: arbor Pharmaceuticals, LLC. Atlanta, GA 30328", "product_quantity": "244 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "78520"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0522-2021", "product_description": "Belsomra (suvorexant) tablets 10 mg Each tablet contains 10 mg suvorexant.  This package contains 30 Tablets in 3 Blister Cards.  Each Blister Card contains 10 Tablets Rx only NDC 00006-0033-30 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA", "product_quantity": "119 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1791139"}, {"status": "Terminated", "city": "South San Francisco", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87724", "recalling_firm": "Genentech Inc", "address_1": "1 Dna Way", "address_2": "N/A", "postal_code": "94080-4918", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-0357-2021", "product_description": "Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution, Rx only, Distributed by: Genentech, Inc. NDC:50242-175-05", "product_quantity": "2,627 bottles", "reason_for_recall": "Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.", "recall_initiation_date": "20210420", "center_classification_date": "20210429", "termination_date": "20220118", "report_date": "20210505", "code_info": "Lot #: B1001B05; B1001B08, Exp. Feb-2022", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208658"], "brand_name": ["SYNJARDY"], "generic_name": ["EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0280", "0597-0290", "0597-0295", "0597-0300"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EMPAGLIFLOZIN", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1862685", "1862688", "1862691", "1862692", "1862695", "1862697", "1862700", "1862701"], "spl_id": ["d7868c65-597e-4cc0-8fac-58f2c7bdb7be"], "spl_set_id": ["8006ba29-ee3a-f852-a9bb-c8ec9b41cf66"], "package_ndc": ["0597-0280-36", "0597-0280-73", "0597-0280-90", "0597-0290-20", "0597-0290-59", "0597-0290-74", "0597-0295-61", "0597-0295-78", "0597-0295-88", "0597-0300-20", "0597-0300-45", "0597-0300-93"], "is_original_packager": [true], "nui": ["N0000187059", "N0000187058"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "unii": ["HDC1R2M35U", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0459-2021", "product_description": "Synjardy XR (empagliflozin and metformin) hydrochloride extended-release) Tablets 12.5 mg/1000 mg 60 tablets Rx only NDC 0597-0300-45 Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "751 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3190949"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078906"], "brand_name": ["VERAPAMIL HYDROCHLORIDE"], "generic_name": ["VERAPAMIL HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-260", "68462-292", "68462-293"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VERAPAMIL HYDROCHLORIDE"], "rxcui": ["897640", "897649", "897659"], "spl_id": ["d1db2ec0-ce9d-4f3a-a2ca-c85b752a09a7"], "spl_set_id": ["ba1bf1ae-9347-4d17-998b-14bf7b5984ce"], "package_ndc": ["68462-292-90", "68462-292-01", "68462-292-05", "68462-293-90", "68462-293-01", "68462-293-05", "68462-260-30", "68462-260-90", "68462-260-01", "68462-260-05", "68462-260-10"], "is_original_packager": [true], "upc": ["0368462292013", "0368462260012", "0368462293010", "074301920558"], "unii": ["V3888OEY5R"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0483-2021", "product_description": "Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462-292-01 Manufactured by: Glenmark Generics Ltd Colvale-Bardez, Goa 403513, India  Manufactured for: Glenmark Generics Inc., USA Mahwah, NJ 07430", "product_quantity": "513 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "19205584"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211061"], "brand_name": ["HALOPERIDOL"], "generic_name": ["HALOPERIDOL"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "product_ndc": ["0832-1510", "0832-1520", "0832-1530", "0832-1540", "0832-1550", "0832-1560"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HALOPERIDOL"], "rxcui": ["197754", "310670", "310671", "310672", "314034", "314035"], "spl_id": ["326f5ed0-bc46-a1f5-e063-6394a90af2c1"], "spl_set_id": ["afb3ac3e-7459-42d3-b5ca-e0d6d27ced73"], "package_ndc": ["0832-1510-11", "0832-1520-11", "0832-1520-89", "0832-1520-01", "0832-1530-11", "0832-1540-11", "0832-1540-89", "0832-1540-01", "0832-1550-11", "0832-1550-89", "0832-1550-01", "0832-1560-11"], "is_original_packager": [true], "upc": ["0308321510117", "0308321530115", "0308321550113", "0308321560112", "0308321520116", "0308321540114"], "nui": ["N0000180182"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "unii": ["J6292F8L3D"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0593-2021", "product_description": "HALOPERIDOL TABLETS 20mg, USP, 100-count bottle, Rx Only Distributed by: Usher-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC: 0832-1560-11", "product_quantity": "35 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2007346C"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0468-2021", "product_description": "BENICAR 40MG 30; NDC/UPC 65597010430; RX; TABLETS", "product_quantity": "75 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1703296"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0539-2021", "product_description": "ZOLPIDEM TARTRATE SUBLINGUAL TABLET 3.5 MG  30 UNIT DOSE POUCHES; NDC/UPC 49884089911; RX;  EACH POUCH CONTAINS ONE SUBLINGUAL TABLET", "product_quantity": "55 Boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "12699501"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA073135"], "brand_name": ["METOCLOPRAMIDE"], "generic_name": ["METOCLOPRAMIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-4502"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["METOCLOPRAMIDE HYDROCHLORIDE"], "rxcui": ["311670"], "spl_id": ["e640a87c-7ee3-4ca2-9808-3916bfd1a54b"], "spl_set_id": ["cccf04bd-7463-40b8-a41f-cb1093c358d7"], "package_ndc": ["0703-4502-01", "0703-4502-04"], "is_original_packager": [true], "unii": ["W1792A2RVD"]}, "product_type": "Drugs", "event_id": "87875", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0377-2021", "product_description": "Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04", "product_quantity": "3,138/25 single use vials per tray", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210426", "center_classification_date": "20210514", "termination_date": "20240604", "report_date": "20210526", "code_info": "Lot # 31325459B, exp. date 08/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA208026"], "brand_name": ["JENTADUETO XR"], "generic_name": ["LINAGLIPTIN AND METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0270", "0597-0275"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LINAGLIPTIN", "METFORMIN HYDROCHLORIDE"], "rxcui": ["1796089", "1796091", "1796094", "1796096"], "spl_id": ["bded948b-6ae6-41aa-bc63-9600660a8dfc"], "spl_set_id": ["3d02a4d4-d312-80b4-05c4-691b8f0aa7aa"], "package_ndc": ["0597-0270-12", "0597-0270-73", "0597-0270-94", "0597-0275-33", "0597-0275-81", "0597-0275-88"], "is_original_packager": [true], "nui": ["N0000175912", "N0000175913"], "pharm_class_moa": ["Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "pharm_class_epc": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "unii": ["3X29ZEJ4R2", "786Z46389E"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0457-2021", "product_description": "Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets 5 mg/1000 mg 30 tablets Rx only NDC 0597-0275-33 Dist. by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA", "product_quantity": "52 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "3189866"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0477-2021", "product_description": "FLOVENT DISKUS 100MCG 60; NDC/UPC 173060202; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "237 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "9E9A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0525-2021", "product_description": "ASMANEX TWST 220MCG 60INH PWD; NDC/UPC 85134102; RX; INHALER MEDICAL INTERNAL - MAY OR MAY NOT BE AEROSOL", "product_quantity": "122 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "T023471"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0410-2021", "product_description": "Atropine Sulfate Ophthalmic Solution, USP 1% For Topical Application To The Eye Sterile 5 mL Rx only NDC 17478-215-05 Manufactured by: Akorn, Inc.", "product_quantity": "424 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "071520A"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0400-2021", "product_description": "THERAPEUTIC M 130; NDC/UPC 740985223680; OTC; TABLETS", "product_quantity": "55 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0504-2021", "product_description": "Ferrous Sulfate 75 mg (equivalent to 15 mg Iron) Per 1.0 mL Alcohol 0.2% v/v Drops Iron Supplement Drops For Infants and Toddlers 50 mL (1 2/3 fl oz) NDC 54838-011-50 Manufactured by: Silarx Pharmaceuticals, Inc. 19 West Street Spring Valley, NY 10977 USA", "product_quantity": "357 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204065"], "brand_name": ["DESVENLAFAXINE"], "generic_name": ["DESVENLAFAXINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-3659", "0591-4060", "0591-3660"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESVENLAFAXINE SUCCINATE"], "rxcui": ["1607617", "1874553", "1874559"], "spl_id": ["9ae096b1-2fff-4410-b1c5-799171a05d54"], "spl_set_id": ["617476f9-62d7-40ef-a1b1-c349d4ad706f"], "package_ndc": ["0591-4060-30", "0591-3659-30", "0591-3660-30"], "is_original_packager": [true], "unii": ["ZB22ENF0XR"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0581-2021", "product_description": "Desvenlafaxine Extended-Release Tablets 25 mg 30 Tablets Rx Only NDC 0591-4060-30 Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA", "product_quantity": "57 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1399650A"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA209637"], "brand_name": ["OZEMPIC"], "generic_name": ["SEMAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-4772", "0169-4136", "0169-4132", "0169-4130", "0169-4181"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["SEMAGLUTIDE"], "rxcui": ["1991306", "1991311", "1991316", "1991317", "2398841", "2398842", "2599362", "2599365", "2619152", "2619154"], "spl_id": ["247a5bbc-e98e-47a7-ad4f-65b387b4918c"], "spl_set_id": ["adec4fd2-6858-4c99-91d4-531f5f2a2d79"], "package_ndc": ["0169-4136-11", "0169-4136-02", "0169-4132-90", "0169-4132-97", "0169-4132-11", "0169-4132-12", "0169-4130-01", "0169-4130-13", "0169-4772-11", "0169-4772-12", "0169-4772-90", "0169-4772-97", "0169-4181-03", "0169-4181-13", "0169-4181-90", "0169-4181-97"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["53AXN4NNHX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0617-2021", "product_description": "OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx only, Novo Nordisk Inc, Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-4132-90 (Pen), NDC 0169-4132-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KP50867, exp 10/31/2022,   KP53021, exp 04/30/2023,   KP52338, exp  02/28/2023,   JP54354, exp 08/31/2022,   KP50676, exp  10/31/2022,   KP51434, exp 11/30/2022,   KP51491, exp  11/30/2022,   KP51781, exp 01/31/2023,  KP52249, exp 01/31/2023,   KP52270, exp  01/31/2023,   KP52722, exp 01/31/2023,   KP52973, exp 01/31/2023,   KP53031, exp  01/31/2023,  KP53221, exp 12.04.2023,   KP53369, exp 01/31/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["HYDROCORTISONE ACETATE"], "generic_name": ["HYDROCORTISONE ACETATE"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-7090", "0574-7093"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RECTAL"], "substance_name": ["HYDROCORTISONE ACETATE"], "rxcui": ["1291082", "1291085"], "spl_id": ["5ae35aec-6ba9-48b8-8b5f-c1b5accb9e1c"], "spl_set_id": ["2fdb9940-6da8-49b0-a236-9817943f7a4b"], "package_ndc": ["0574-7090-12", "0574-7093-12"], "is_original_packager": [true], "unii": ["3X7931PO74"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0550-2021", "product_description": "HYDROCORTISONE ACET 30MG 12; RX; SUPPOSITORY,Rx Only, Distributed by: Perrigo, Allegan, MI 49010, NDC: 0574-7093-12", "product_quantity": "95 suppositories", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "433202"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0556-2021", "product_description": "Chantix (varenicline) Tablets Starting Pack Contains: 1 Starting Week (0.5 mgx11 tablets) 3 Continuing Weeks (1 mgx42 tablets) Rx only NDC 0069-0471-03 Distributed by Pfizer Labs Division of Pfizer, Inc., NY, NY 10017", "product_quantity": "1040 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EC5911"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022341"], "brand_name": ["VICTOZA"], "generic_name": ["LIRAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-4060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["LIRAGLUTIDE"], "rxcui": ["897122", "897126"], "spl_id": ["0d10d10e-0fe0-47ee-b9da-628e34907e98"], "spl_set_id": ["5a9ef4ea-c76a-4d34-a604-27c5b505f5a4"], "package_ndc": ["0169-4060-13", "0169-4060-12", "0169-4060-90", "0169-4060-97", "0169-4060-98", "0169-4060-99"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["839I73S42A"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0622-2021", "product_description": "ViCTOZA (liraglutide) injection, 18 mg/3 mL (6 mg/mL), contains: 1 Victoza Pen, Sample Not for Resale, Rx only, Manufactured by: Novo Nordisk A/S, Bagesvaerd, Denmark  NDC 0169-4060-90 (Pen), 0169-4060-99 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "I2419A (Kit); JS68K86 (Pen) exp 05/31/2021"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 60"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313391", "1724481"], "spl_id": ["1eed1f06-6d04-4057-87ed-782c6850e7d2"], "spl_set_id": ["f347f490-7199-4de6-bca2-0d44a74979af"], "package_ndc": ["42192-330-30", "42192-330-01", "42192-330-10"], "is_original_packager": [true], "upc": ["0342192330108"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "87843", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States including Puerto Rico", "recall_number": "D-0397-2021", "product_description": "NP Thyroid 60 Thyroid Tablets, USP 1 grain (60 mg) 100-count bottles, Rx Only Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-330-01", "product_quantity": "154,726 bottles", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210429", "center_classification_date": "20210524", "termination_date": "20240313", "report_date": "20210602", "code_info": "Lots: M330D20-1, M330D20-2 Exp. 03/31/2022; M330J19-2A,  M330J19-4A , M330J19-5A,  M330J19-6A, M330J19-7A, M330J19-9A Exp. 08/31/2021; M330K19-10, M330K19-1A, M330K19-9 Exp. 09/30/2021"}]